• Edgewise Therapeutics granted inducement stock options covering 16,500 common shares to two new non-executive employees on June 30, 2026.
• Options carry a $40.63 exercise price, set at the closing share price on the grant date.
• Vesting starts with 25% on each employee’s one-year start-date anniversary, then monthly in 1/48 increments, subject to continued service.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edgewise Therapeutics Inc. published the original content used to generate this news brief on July 01, 2026, and is solely responsible for the information contained therein.